GSE214931 temozolomide 4 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE214931_temozolomide_4_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE214931_temozolomide_4_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE214931_temozolomide_4_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE214931_temozolomide_4_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

OIP5 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1116

Gene

long intergenic non-protein coding RNA 2762

Gene

coiled-coil domain containing 92B

Gene

cytochrome P450 family 4 subfamily F member 29, pseudogene

Gene

long intergenic non-protein coding RNA 1444

Gene

PRKAR1B antisense RNA 1

Gene

MIR3681 host gene

Gene

EGFLAM antisense RNA 5

Gene

EPHA5 antisense RNA 1

  • Gene

    OIP5 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1116


  • Gene

    long intergenic non-protein coding RNA 2762


  • Gene

    coiled-coil domain containing 92B


  • Gene

    cytochrome P450 family 4 subfamily F member 29, pseudogene


  • Gene

    long intergenic non-protein coding RNA 1444


  • Gene

    PRKAR1B antisense RNA 1



  • Gene

    EGFLAM antisense RNA 5


  • Gene

    EPHA5 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.